GeneNet Limited is a pioneering biotech company focusing on cell engineering and genetic circuit technology, powered by cutting-edge artificial intelligence (AI). Using our patent-protected “AI+Bioinformatics” platform, we explore molecular mechanisms in cells and identify targets for gene editing. We use our AI platform to develop stable cell lines/organoids for various applications. We are working on multiple projects, such as developing drug discovery platforms using intelligent cardiac organoids, in partnership with global biotechnology companies and universities. Our core team members have extensive skills in the field, including scientists with PhD degrees from world-class universities, such as the University of Cambridge, and entrepreneurs with successful start-up experience.
Dr Seak Chi-u (Graduate, University of Cambridge)
Dr Wu Ming-tsung (Graduate, National Taiwan University)
Mr Lo Lok-in (PhD student, University of Edinburgh)
(Info based on the company's application form)
- CityU HK Tech 300 Angel Fund (2023)
- HKSTP IDEATION Programme (2021)
- 160+ Global Finalists, HKSTP Elevator Pitch Competition 2021